OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
Jill Wechsler is BioPharm International's Washington Editor, firstname.lastname@example.org.
October 21, 2021
FDA is expanding its Emerging Technology Program and providing more support for new drug applications that present advanced manufacturing technologies.
November 02, 2020
Experts fear confusion over allocation processes, cold-chain requirements, and IT systems needed to bring a COVID-19 vaccine to market.
September 02, 2020
Regulators strive to review flood of advanced treatments while also vetting COVID-19 vaccines.
August 24, 2020
FDA announced it had issued an emergency use authorization for convalescent plasma that would make it easier to provide this treatment to COVID-19 patients.
December 02, 2019
Problems in assuring reliable drug quality and supply dampens progress in bringing lifesaving therapies to market.